UK Legislators Get Involved In NICE’s Methods Review
A UK parliamentary panel examining a wide range of issues affecting the availability of new treatments on the National Health Service is collecting evidence on possible topics that might be covered under the upcoming review of the appraisal methods used by health technology assessment body NICE. NICE itself is not publicly consulting on the scope of the review.
You may also be interested in...
The UK's HTA body, NICE, says a more scientific criteria should be used to decide how many products should be admitted to its program for evaluating highly specialized technologies.
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
From grappling with a never-ending list of conflicting national requirements to dealing with numerous technical issues, a research project manager at Norway’s Oslo University Hospital talks about the hiccups faced by their multinational COVID-19 platform trial that was among the first studies submitted for approval under the EU Clinical Trial Regulation.